期刊文献+

六氧甲基鸟嘌呤DNA甲基转移酶基因表达与肿瘤耐药 被引量:6

O6-Methylguanine-DNA methyltransferase gene expression and chloroethylnitrosourea resistance in human tumor cell lines
下载PDF
导出
摘要 目的:六氧甲基鸟嘌呤DNA甲基转移酶(MGMT)能阻止由氮芥类导致的DNA交连形成,因而降低其细胞毒性。本研究探讨肿瘤细胞对氯乙基亚硝脲(CENU)耐药与其MGMT基因表达之间的关系。方法:采用RNA印迹试验和蛋白印迹试验对13株人肿瘤细胞的MGMT基因表达进行了检测,并与采用改良的SulforhodaminaB(SRB)比色抗癌药筛选法测定的肿瘤细胞对CENU的耐药性进行比较。结果:肿瘤细胞MGMT的表达在mRNA水平和蛋白水平是一致的。MGMT阳性的肿瘤比MGMT阴性的肿瘤对BCNU(t=2.611,P=0.01)和SarCNU(t=2.558,P=0.01)明显耐药。可是,MGMT表达高低与肿瘤细胞耐药性程度之间无线性相关。结论:MGMT在肿瘤细胞对CENU耐药中起重要作用,但除了MGMT之外,还有其它机制参与肿瘤耐药。 Purpose: 06-methylguanine-DNA methyltransferase (MGMT) can provent the formation of DNA crosslink induced by nitrosoureas, so that the cytotoxicity of these reagents was reduced. This study is to investigate the relationship between chloroethylnitrosourea (CENU) resistance and MGMT expression in tumor cell lines. Methods: We evaluated MGMT gene expression utilizing Northern blot and Western blot analysis, and compared these results with CENU cytotoxicity as dertermined by a modified sulforhodamine B (SRB) colorimetric anticancer-drug screening assay, in 13 human tumor cell lines. Results: MGMT expression at mRNA level is in concordance with the protein level. MGMT positive cell lines are more resistant than MGMT negative cell lines to 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU)(t=2.611,P=0.01) and to 2-chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU)(t=2.558,P=0.01). However, there was no linear correlation between MGMT expression and CENU cytotoxicity. Conclusions: Our results suggest that MGMT plays an important role in CENU resistance of human tumors, while mechanisms other than MGMT may also involving in drug resistance.
出处 《癌症》 SCIE CAS CSCD 北大核心 1998年第3期182-185,共4页 Chinese Journal of Cancer
基金 美国NHI基金
关键词 六氧甲基鸟嘌呤 药理学 肿瘤 耐药性 MGMT methylguanine-DNA methyltransferase Chemotherapy Drug resistance
  • 相关文献

参考文献4

同被引文献28

  • 1张俊英,陈忠平.MGMT基因表达与人脑胶质瘤化疗耐药关系研究[J].中国神经肿瘤杂志,2003,1(4):200-204. 被引量:12
  • 2王亮,吴旻.O^6-甲基鸟嘌呤-DNA甲基转移酶与肿瘤[J].国外医学(肿瘤学分册),1994,21(3):129-131. 被引量:8
  • 3陈建文,张俊平,程金建,陈建良,史鸿浏,张俊英,牟永告,张湘衡,周旺宁,赛克,陈忠平.体外药敏试验指导的恶性脑胶质瘤预见性化疗[J].广东医学,2005,26(9):1183-1185. 被引量:17
  • 4Silber JR, Blank A, Bobola MS, et al. O6-methylguanine-DNA methyltransferase-deficient pheaotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy [ J ]. Clinical Cancer Res, 1999,5 (4):807-814. 被引量:1
  • 5Tong W, Kirk M,Ludlum D. Formation of the cross-link 1-[N3-deoxycytidyl],2-[N1-deoxyguanosinyl]-ethane in DNA treated with N, N1-bis(2 - chlomethyl)-N-nitrosorea[J]. Cancer Res,1982,42:3102. 被引量:1
  • 6Silber JR, Bolsa MS, Ghatan S, et al. O6-methylguanine-DNA methytranferase activity in adult gliomas relation to patient and tumor characteristics[J]. Cancer Res, 1998,58 ( 3 ) : 1068-1073. 被引量:1
  • 7Nagane M,Asai A,Shibui S, et al. Expression pattern of chemoresistance-related for proper selection of anticancer drugs[J]. Jpa J Clin Oncol, 1999,29 ( 1 ) :527-534. 被引量:1
  • 8Pegg, AE. O^6-methylguanine DNA methyltransferase activity in breast and brain tumors [J]. Cancer Res, 1990, 50: 6199. 被引量:1
  • 9Preuss I, Eberhagen I, Haas S, et al. Mammalian O^6 alkyluanine DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents [ J ]. Int J Cancer, 1995, 61 ( 3 ) :321-326. 被引量:1
  • 10Bobola MS, Blank A, Berger MS, et al. Contribution of O^6-to resistance to 1, 3- (2-chloroethyl) -1-nitrosourea in human brain tumor-derived cell lines [J]. Mol Carcinogenesis, 1995, 13: 81. 被引量:1

引证文献6

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部